Electromed (NSDQ:ELMD) said it settled legal beefs with its co-founder and former CEO, Robert Hansen, and ex-marketing director Eileen Manning over the composition of the medical device company’s board.
Electromed
Ex-KCI CEO Burzik dives into venture capital | Personnel Moves
Medical device moves: Marketing veep Trujillo out at Conceptus
Abiomed swings to 2011 black on record Q4 revenues | Earnings Roundup
Abiomed (NSDQ:ABMD) set off a Wall Street roller coaster with its latest earnings release, in which the Danvers, Mass.-based heart pump maker posted its 1st profitable year in a decade and a half.
The 3 months ended March 31 made up Abiomed’s "best quarter and year in company history, in terms of number of patients supported, revenue growth, and profitability," chairman, president & CEO Michael Minogue said in prepared remarks.
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed (NSDQ:ELMD) founder, chairman & CEO Robert Hansen relinquished control of the company after 20 years steering the ship.
Stryker ex-CEO MacMillan resigns from Texas Instruments board | Personnel Moves
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.
Masimo meets The Street, shares rise | Earnings Roundup
Masimo (NSDQ:MASI) met Wall Street’s forecast for its full-year and 4th-quarter earnings, giving its shares a 2% bump yesterday and sending them another 3% higher today.
The Irvine, Calif.-based patient monitoring systems maker reported profits of $$13.8 million, or 23 cents per share, on sales of $112.3 million for the 3 months ended Dec. 31, 2011, for a top-line increase of 6.4% but a bottom-line decline of 14.2%, compared with Q4 2010.
Electromed: Q2, H2 2012 sales, earnings growth to slow | Wall Street Beat
Electromed (NSDQ:ELMD) CEO Robert Hansen said the company expects its sales and earnings numbers to slide for the 2nd quarter and 2nd half of 2012, after a sales force restructuring hit its top line.
Accuray dives despite beating The Street as losses gape | Earnings Roundup
Accuray (NSDQ:ARAY) shares are down today after the radiosurgery company reported surging first-quarter sales and beat Wall Street’s earnings expectations, as investors reacted to net losses of nearly six times the Q1 2011 mark.
Accuray reported losses of $26.5 million, or 38 cents per share, on sales of $100.5 million for the three months ended Sept. 30. That’s top-line growth of 163.9 percent compared with the same period last year, largely due to the massive infusion that followed ARAY’s acquisition of rival TomoTherapy earlier this year.
Electromed promotes Jeremy Brock to CFO after 3 months | Personnel Moves
Electromed Inc. (NSDQ:ELMD) promoted Jeremy Brock to the position of chief financial officer, effective immediately.
Brock just joined the New Prague, Minn.-based company as its financial controller in August, 2011.
Electromed switches to Euronext exchange
Electromed Inc. (NSDQ:ELMD) plans to switch from the Nasdaq Capital Market exchange to NYSE Amex beginning next month.
The New Prague, Minn.-based airway clearance device firm, which went public last year, will continue to trade under the ELMD ticker on the new exchange.